These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34027858)

  • 21. A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma.
    Otb S; Shaarawy E; Sadek A; Abdallah N; Agamia N; Soliman M; Tawfik AA
    J Dermatolog Treat; 2022 Feb; 33(1):555-559. PubMed ID: 32420770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of oral vs different dilutions of intradermal tranexamic acid microinjections in melasma-A randomized clinical trial.
    El Hadidi H; Mosaad R; Ragab N
    Dermatol Ther; 2021 May; 34(3):e14924. PubMed ID: 33651442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Split-face comparative study between intradermal tranexamic acid injection alone versus intradermal tranexamic acid injection combined with Q-switched Nd:YAG laser in melasma treatment: dermoscopic and clinical evaluation.
    Hawwam SA; Ismail M; El-Attar YA
    Lasers Med Sci; 2022 Jun; 37(4):2193-2201. PubMed ID: 34988730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New local treatments for different types of melasma: Vascular type vs nonvascular type. A randomized polycentric study.
    Fioranelli M; Jafferany M; Wollina U; Tirant M; Van Thuong N; Lotti T
    Dermatol Ther; 2020 May; 33(3):e13300. PubMed ID: 32157765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-rich plasma treatment for melasma: A pilot study.
    Sirithanabadeekul P; Dannarongchai A; Suwanchinda A
    J Cosmet Dermatol; 2020 Jun; 19(6):1321-1327. PubMed ID: 31568636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic efficacy and safety of oral tranexamic acid 250 mg once a day versus 500 mg twice a day: a comparative study.
    Chowdhary B; Mahajan VK; Mehta KS; Chauhan PS; Sharma V; Sharma A; Vashist S; Kumar P
    Arch Dermatol Res; 2021 Mar; 313(2):109-117. PubMed ID: 32356007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up.
    Behrangi E; Shemshadi M; Ghassemi M; Goodarzi A; Dilmaghani S
    J Cosmet Dermatol; 2022 Jan; 21(1):279-289. PubMed ID: 34724323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-Rich Plasma in Melasma-A Systematic Review.
    Sarkar R; Gupta M
    Dermatol Surg; 2022 Jan; 48(1):131-134. PubMed ID: 34904579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral tranexamic acid lightens refractory melasma.
    Tan AWM; Sen P; Chua SH; Goh BK
    Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study.
    Sharma R; Mahajan VK; Mehta KS; Chauhan PS; Rawat R; Shiny TN
    Clin Exp Dermatol; 2017 Oct; 42(7):728-734. PubMed ID: 28649780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the efficacy of intradermal injected tranexamic acid vs hydroquinone cream in the treatment of melasma.
    Pazyar N; Yaghoobi R; Zeynalie M; Vala S
    Clin Cosmet Investig Dermatol; 2019; 12():115-122. PubMed ID: 30858717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of autologous platelet rich plasma and hydroquinone 4% is more effective than hydroquinone alone in treatment of melasma: A split-face comparative study.
    Tekam PS; Belgaumkar VA
    Dermatol Ther; 2022 Nov; 35(11):e15761. PubMed ID: 36068674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of melasma with platelet-rich plasma: A self-controlled clinical trial.
    González-Ojeda A; Cervantes-Guevara G; Chejfec-Ciociano JM; Cervantes-Cardona GA; Acevedo-Guzman D; Puebla-Mora AG; Cortés-Lares JA; Chávez-Tostado M; Álvarez-Villaseñor AS; Cervantes-Pérez E; Ramos-Álvarez MP; Pacheco-Vallejo LR; Barbosa-Camacho FJ; Fuentes-Orozco C
    Dermatol Ther; 2022 Sep; 35(9):e15703. PubMed ID: 35831241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.
    Kanechorn Na Ayuthaya P; Niumphradit N; Manosroi A; Nakakes A
    J Cosmet Laser Ther; 2012 Jun; 14(3):150-4. PubMed ID: 22506692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of intradermal injection of tranexamic acid and ascorbic acid versus tranexamic acid and placebo in the treatment of melasma: A split-face comparative trial.
    Pazyar N; Molavi SN; Hosseinpour P; Hadibarhaghtalab M; Parvar SY; Dezfuly MB
    Health Sci Rep; 2022 Mar; 5(2):e537. PubMed ID: 35284654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intradermal application of tranexamic acid (TA) as treatment of melasma in the out-patients department of a public sector hospital: A pilot study.
    Mehmood M; Ali M; Saleem MA; Asghar S; Hussain MT; Mehmood A
    J Pak Med Assoc; 2022 Nov; 72(11):2275-2277. PubMed ID: 37013301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tranexamic acid microinjections versus tranexamic acid mesoneedling in the treatment of facial melasma: A randomized assessor-blind split-face controlled trial.
    Poostiyan N; Alizadeh M; Shahmoradi Z; Fatemi Naeini F
    J Cosmet Dermatol; 2023 Apr; 22(4):1238-1244. PubMed ID: 36606390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tranexamic acid as a therapeutic option for melasma management: meta-analysis and systematic review of randomized controlled trials.
    Calacattawi R; Alshahrani M; Aleid M; Aleid F; Basamih K; Alsugair G; Alqahtani R; AlKhabbaz N; Algaidi Y; Alrakayan L; Almohanna A; Madkhali A; Aljohani S; Alotibi N
    J Dermatolog Treat; 2024 Dec; 35(1):2361106. PubMed ID: 38843906
    [No Abstract]   [Full Text] [Related]  

  • 40. Tranexamic Acid in Melasma: Comparative Evaluation of Therapeutic Efficacy of Oral Tranexamic Acid versus Its Transepidermal Administration.
    Batra J; Brar BK; Kumar S; Arora H
    J Cutan Aesthet Surg; 2022; 15(4):394-399. PubMed ID: 37035597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.